Associate Professor Jonathan Emberson
BA, MSc, PhD
Associate Professor, Medical Statistics and Epidemiology
- MRC PHRU Programme Leader
- NDPH Deputy Director of Graduate Studies
- Clinical Trial Service Unit
- MSC in Global Health Science Module Lead: Clinical Trials and Meta-Analysis
Jonathan is a Senior Statistican at the Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU). He joined CTSU in 2004 after completing his undergraduate degree in Mathematics and postgraduate degrees in Statistics and Epidemiology. He is now the statistical lead for CTSU’s Vascular Overviews and Renal Studies Groups, and is CTSU’s principal investigator for the Mexico City Prospective Study of 150,000 middle-aged Mexican adults. His main research interests are studying the causes and prevention of cardiovascular disease, with a particular emphasis on large-scale individual participant meta-analyses of both observational and randomised studies.
Campath, calcineurin inhibitor reduction, and chronic allograft nephropathy (the 3C Study) - results of a randomized controlled clinical trial.
3C Study Collaborative Group None., (2018), Am J Transplant, 18, 1424 - 1434
Effect of diabetes duration and glycaemic control on 14-year cause-specific mortality in Mexican adults: a blood-based prospective cohort study.
Herrington WG. et al, (2018), Lancet Diabetes Endocrinol, 6, 455 - 463
Sex-specific relevance of diabetes to occlusive vascular and other mortality: Meta-analysis of individual data from 68 prospective studies with 77,000 deaths among 1 million adults
Lewington S. et al, (2018), The Lancet Diabetes and Endocrinology
Impact of CKD on Household Income.
Morton RL. et al, (2018), Kidney Int Rep, 3, 610 - 618
Declining comorbidity-adjusted mortality rates in English patients receiving maintenance renal replacement therapy.
Storey BC. et al, (2018), Kidney Int, 93, 1165 - 1174